Pharma Law USA
The only pharma event examining antitrust, IP, fraud, compliance & regulation in one place. Your one-stop shop to dissect the latest legal developments affecting pharma.
Avoid costly fines and disputes. Gain practical strategies and connect with in-house counsel, regulators & top legal minds.
Brought to you by Informa.
Reasons to attend Informa's Pharma Law USA 2024:
Explore currently developing legal challenges for the pharmaceutical industry, from every angle.
Current challenges in pricing:
- Hatch-Waxman Act at 40: Is it Still Fit for Purpose?
- Inflation Reduction Act, March-in Rights & Other Developments in Pricing
- Navigating 340B Drug Program Litigation
Patents & IP:
- Hot Topics in Patents including Orange Book Cases & Patent Eligibility
- Update on Reverse Payment Settlements
- How are the Courts Approaching Product Hopping?
Merger control:
- Review of FTC Guidelines & Lessons Learnt from Recent Mergers
Emerging trends:
- Psychedelics as Pharmaceuticals
- The Risks & Opportunities of AI
- IP in Medical Devices
- Biologics & Biosimilars
Prosecutions & compliance:
- AGs Roundtable
- Recent Perspectives on Healthcare Prosecutions
- Compliance: Best Practice
Meet the pharma industry in Boston
Make connections that matter during our specially designed structured speed networking session, and continue the conversation during informal drinks.
- In-house counsel from across the pharma sector
- Private practice lawyers
- Authorities and regulators
- Antitrust economists
Connect with the Pharma Industry in Boston:
During the specially designed structured speed networking session followed by an informal drinks reception, giving you an opportunity to make new connections and catch up with your peers.
Why attend Informa Connect events?
Showcase your firm to future clients:
Showcase your knowledge and expertise to a top level audience from across the pharma sector - including a high proportion of in-house counsel.
Get in touch with Thomas Martins to discuss speaking, branding and exhibition opportunities.
